Yang and colleagues demonstrated that epigenetic alterations with enhancer hijacking secondary to the deletion of the PAN3 gene (13q12.2) explain elevated FLT3 expression in B-ALL patients, particularly among those with hyperdiploidy or those who experienced relapse. The gene discussed is PAN3; the disease is acute lymphoblastic leukemia.